Alexander C. J. van Akkooi

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà et al. · New England Journal of Medicine · 2018 · 1.8K citations · Full text

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

Hanjie Li, Anne M. van der Leun, Ido Yofe et al. · Cell · 2018 · 1.1K citations · Full text

Cancer Immunosurveillance, Human Melanoma, T-regulatory Cell +8

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 833 citations

Medicine, Melanoma, Immunology +6

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Olivier Michielin, Alexander C. J. van Akkooi, Paolo A. Ascierto et al. · Annals of Oncology · 2019 · 606 citations · Full text

Dermoscopic Image, Melanoma, Cutaneous Melanoma +3

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial

Elisa A. Rozeman, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · The Lancet Oncology · 2019 · 498 citations

Oncology, Medicine, Melanoma +6